Ausgabe 5/2023
Inhalt (35 Artikel)
Treatment of hydroxyurea-resistant/intolerant polycythemia vera: a discussion of best practices
Andrew T. Kuykendall
Stem cell mobilization in multiple myeloma: challenges, strategies, and current developments
Xiaolei Wei, Yongqiang Wei
Superiority of polatuzumab vedotin over other novel agents in previously untreated ABC-type diffuse large B-cell lymphoma: a network meta-analysis of 20 RCTs
Zhixin Sheng, Dianfang Li, Bing Chen, Chunwu Zhao, Wenxing Zhang, Baolong Ding, Lida Wang
Estimated glomerular filtration rate in Brazilian adults with sickle cell disease: results from the REDS-III multicenter cohort study
André Rolim Belisário, Ana Cristina Simões e Silva, Isabel Cristina Gomes Moura, Anna Bárbara Carneiro-Proietti, Ester Cerdeira Sabino, Paula Loureiro, Cláudia Máximo, Miriam V. Flor-Park, Daniela de Oliveira Werneck Rodrigues, Mina Cintho Ozahata, Rosimere Afonso Mota, Carla Luana Dinardo, Shannon Kelly, Brian Custer
Targeted next-generation sequencing identifies eighteen novel mutations expanding the molecular and clinical spectrum of PKLR gene disorders in the Indian population
Rashmi Dongerdiye, Meghana Bokde, Tejashree Anil More, Arati Saptarshi, Rati Devendra, Ashish Chiddarwar, Prashant Warang, Prabhakar Kedar
The occurrence of thrombosis during intensive chemotherapy treatment for acute myeloid leukemia patients does not impact on long-term survival
Tamer Hellou, Omri Cohen, Abraham Avigdor, Irina Amitai, Avichai Shimoni, Mudi Misgav, Jonathan Canaani
Diagnostic yield, indications, and outcomes of cranial imaging in AML patients admitted for intensive induction or consolidation chemotherapy: a single-center experience
Sebastian E. Koschade, Jan A. Stratmann, Pia S. Zeiner, Fabian Finkelmeier, Jörg Chromik, Björn Steffen, Hubert Serve, Christian H. Brandts, Olivier Ballo
Epidemiology and early mortality patterns of acute promyelocytic leukemia in the United States
Aditi Sharma, Jay Yang, Vijendra Singh
Loss of IRF8 inhibits the growth of acute myeloid leukemia cells
Haihui Zhuang, Fenglin Li, Yulian Xu, Renzhi Pei, Dong Chen, Xuhui Liu, Shuangyue Li, Peipei Ye, Jiaojiao Yuan, Jiaying Lian, Ying Lu
Lycorine induces apoptosis of acute myeloid leukemia cells and inhibits triglyceride production via binding and targeting FABP5
Xinming Liang, Wenli Fu, YuHui Peng, Juanjuan Duan, Ting Zhang, Daogui Fan, Wei Hong, Xiaolan Qi, ChangXue Wu, Yan He, Wenfeng Yu, Jing Zhou, Pengxiang Guo, Hua Bai, Qifang Zhang
PH negative acute lymphoblastic leukemia in adolescents and young adults treated according a MRD adapted BFM ALL IC 2009 protocol: Argentine real-world data on 171 patients
Luciana C Ferrari, María M Rivas, Alicia B Navickas, Hernán Dick, María J Mela Osorio, Lucía Agamennoni, Irene H Rey, Natalia E Carnelutto, Nicolás Cazap, María B Castro, Pedro Negri Aranguren, Laura A Fischman, Marco Lincango Yupanki, Jorge H Milone, Isolda I Fernández, María M Moirano, Carolina B Belli
Multicenter retrospective analysis of clinical outcome of adult patients with mixed-phenotype acute leukemia treated with acute myeloid leukemia–like or acute lymphoblastic leukemia–like chemotherapy and impact of allogeneic stem cell transplantation: a Campus ALL study
Davide Lazzarotto, Ilaria Tanasi, Antonella Vitale, Matteo Piccini, Michelina Dargenio, Fabio Giglio, Fabio Forghieri, Nicola Fracchiolla, Marco Cerrano, Elisabetta Todisco, Cristina Papayannidis, Matteo Leoncin, Marzia Defina, Fabio Guolo, Crescenza Pasciolla, Mario Delia, Patrizia Chiusolo, Antonino Mulè, Anna Candoni, Massimiliano Bonifacio, Giovanni Pizzolo, Robin Foà
Long term outcomes in older patients with primary central nervous system lymphoma: an analysis of the Texas Cancer Registry
Ethan A. Burns, Cesar Gentille Sanchez, Sunil Mathur, Carlo Guerrero, Ibrahim N. Muhsen, Humaira Sarfraz, Chih-Chi Andrew Hu, Chih-Hang Anthony Tang, Shilpan S. Shah, Ivo W. Tremont, Bin Teh, Siddhartha Ganguly, Sai Ravi Kiran Pingali
Clinical and histopathology characteristics of Castleman disease: a multicenter study of 51 Brazilian patients
Julia Mota Leite, Tomás Zecchini Barrese, Leonardo Sementilli, Leandro Luiz Lopes de Freitas, Kleber Simões do Espirito Santo, Marcia Torresan Delamain, Otávio César Carvalho Guimarães Baiocchi, Sérgio Augusto Buzian Brasil, Carlos Sérgio Chiattone
Pediatric chemotherapy versus allo-HSCT for adolescent and adult Philadelphia chromosome-negative ALL in first complete remission: a meta-analysis
Zengkai Pan, Luxiang Wang, Weijia Fu, Chuanhe Jiang, Zilu Zhang, Qi Chen, Libing Wang, Xiaoxia Hu
Prognostic value of metabolic tumor volume of extranodal involvement in diffuse large B cell lymphoma
Kana Oiwa, Kei Fujita, Shin Lee, Tetsuji Morishita, Tetsuya Tsujikawa, Eiju Negoro, Takeshi Hara, Hisashi Tsurumi, Takanori Ueda, Takahiro Yamauchi
Real-world data from yttrium-90 ibritumomab tiuxetan treatment of relapsed or refractory indolent B-cell non-Hodgkin's lymphoma: J3Zi Study
Ilseung Choi, Masaya Okada, Tomoki Ito
Systemic relapses of primary CNS lymphomas (PCNSL): a LOC network study
J. Dufour, S. Choquet, K. Hoang-Xuan, A. Schmitt, G. Ahle, R. Houot, L. Taillandier, R. Gressin, O. Casasnovas, J.P. Marolleau, J. Tamburini, C. Serrier, E. Perez, J. Paillassa, E. Gyan, A. Chauchet, R. Ursu, A. Kas, C. Soussain, C. Houillier
Real world outcomes of lenalidomide or bortezomib maintenance in patients with multiple myeloma not undergoing stem cell transplantation
Tianhong Xu, Yang Yang, Jing Li, Jiadai Xu, Wenjing Wang, Yawen Wang, Aziguli Maihemaiti, Liang Ren, Tianwei Lan, Chi Zhou, Panpan Li, Pu Wang, Peng Liu
Clinical significance of high-dose chemotherapy with autologous stem cell transplantation in the era of novel agents in patients older than 65 years with multiple myeloma
Shuku Sato, Shun Tsunoda, Teiko Kawahigashi, Wataru Kamata, Yotaro Tamai
CMV infection is a risk factor for hemorrhagic cystitis after hematopoietic stem cell transplantation
Ling Zhang, Bijay Khadka, Jieying Wu, Yashu Feng, Bing Long, Ruozhi Xiao, Jiajun Liu
Feasibility, safety, and efficacy of early prophylactic donor lymphocyte infusion after T cell-depleted allogeneic stem cell transplantation in acute leukemia patients
Boris van der Zouwen, E. A. S. Koster, P. A. von dem Borne, L. E. M. Oosten, M. W. I. Roza-Scholten, T. J. F. Snijders, D. van Lammeren, P. van Balen, W. A. F. Marijt, H. Veelken, J. H. F. Falkenburg, L. C. de Wreede, C. J. M. Halkes
Allogeneic transplantation of bone marrow versus peripheral blood stem cells from HLA-identical relatives in patients with myelodysplastic syndromes and oligoblastic acute myeloid leukemia: a propensity score analysis of a nationwide database
Hidehiro Itonaga, Yasushi Miyazaki, Kazunari Aoki, Naoki Shingai, Yukiyasu Ozawa, Takahiro Fukuda, Keisuke Kataoka, Toshiro Kawakita, Yasunori Ueda, Takahide Ara, Masatsugu Tanaka, Yuta Katayama, Masashi Sawa, Tetsuya Eto, Junya Kanda, Yoshiko Atsuta, Ken Ishiyama
Ferroptosis: a new target for iron overload-induced hemophilic arthropathy synovitis
Zhiwei Han, Liujie Zheng, Dasheng Luo, Nanyu Pang, Yunfeng Yao
Predictive scoring system for distinguishing Stenotrophomonas maltophilia bacteremia from Pseudomonas aeruginosa bacteremia in patients with hematological malignancies
Takashi Sakoh, Muneyoshi Kimura, Shinsuke Takagi, Sho Ogura, Masayo Morishima, Ryosuke Yamamuro, Kyosuke Yamaguchi, Mitsuhiro Yuasa, Daisuke Kaji, Kosei Kageyama, Yuki Taya, Aya Nishida, Kazuya Ishiwata, Hisashi Yamamoto, Go Yamamoto, Yuki Asano-Mori, Atsushi Wake, Naoyuki Uchida, Shuichi Taniguchi, Hideki Araoka
High TOX expression on CD8+ T cells in pure red cell aplasia
Haiyue Niu, Li Yan, Liping Yang, Mengying Zhang, Mengyuan Liu, Jie Ren, Zonghong Shao, Rong Fu, Limin Xing, Huaquan Wang
Effectiveness and management of ponatinib as second-line treatment in chronic myeloid leukemia: an analysis from the monitoring registries of the Italian medicines agency (AIFA)
Massimo Breccia, Pier Paolo Olimpieri, Simone Celant, Odoardo Maria Olimpieri, Fabrizio Pane, Alessandra Iurlo, Valentina Summa, Paolo Corradini, Pierluigi Russo
Use of roxadustat (FG-4592) in ruxolitinib-treatment-related anemia of two myelofibrosis patients
Kai Ding, Zhaoyun Liu, Yue Ren, Hui Liu, Rong Fu
Remarkable response to chidamide plus rituximab in an elderly patient with recurrent, chemotherapy-refractory diffuse larger B-cell lymphoma carrying CREBBP mutation
Dongdong Zhang, Yidi Han, Youhong Dong
Safe and successful CAR T-cell therapy targeting BCMA in a multiple myeloma patient requiring hemodialysis
Ralph Wäsch, Tim Strüssmann, Claudia Wehr, Reinhard Marks, Phillip T. Meyer, Gerd Walz, Monika Engelhardt
Sustained spontaneous remission in KMT2A-MLLT3 mutated myeloid sarcoma
Chris Armstrong, Wing-Yan Au, Edmond S K Ma, Simon Ho Man Wong, Nina Orfali
Venetoclax and blinatumomab based chemotherapy-free treatment in a patient with Philadelphia chromosome-negative acute lymphoblastic leukemia
Jie Chang, Yao-jia Shen, Ting Shi, Hua-Feng Wang, Jie Jin, Hong-Hu Zhu
JAK2 V617F-mutated polycythemia vera developing in a patient with a 20-year-long chronic myeloid leukemia at the time of first molecular response
Luca Tosoni, Dora Fabbro, Umberto Pizzano, Rikard Mullai, Gianluca Morelli, Alessandra Franzoni, Giuseppe Damante, Eleonora Toffoletti, Daniela Damiani, Renato Fanin, Mario Tiribelli
Double-hit follicular lymphoma diagnosed due to central nervous system symptoms
Chika Kawajiri-Manako, Tatsuzo Mishina, Hideki Tsujimura, Satoshi Maruyama, Akiyasu Sato, Takeaki Sugawara, Kyoya Kumagai, Rikiya Nakamura, Makiko Itami, Masahiro Takeuchi
Real-world treatment patterns of venetoclax and azacytidine therapy in Japanese patients with acute myeloid leukemia
Yoshito Gando, Takeo Yasu